This FDA InspectorProfile is a report of relevant audit-related information on Linda Murphy, a U.S. Food & Drug Administration investigator who primarily conducts inspections in the area of Human Drugs.
This InspectorProfile report is updated through and lists Linda Murphy's inspections in 16 countries: United States, India, Belgium, Hong Kong SAR, Switzerland, Italy, Macao, Singapore, Thailand, Austria, Malaysia, Taiwan, Korea (the Republic of), France, Canada, and Japan.
FDA audits are stressful. Whether you are issued a 483 depends largely on your compliance with GxP and predicate rules; but it can also depend on the Agency's current focus and the tendencies of your specific investigator(s). FDAzilla has curated Linda Murphy's inspection information so that you can mitigate investigator-related risks.
Below is an example of what a FDAzilla InspectorProfile report contains; This is not the actual data for Linda Murphy.
Note: The EIR and 483 documents are sold separately.